ZIPDOSE

Serial Number 90859346
606

Registration Progress

Application Filed
Jul 30, 2021
Under Examination
Aug 30, 2022
Approved for Publication
Jul 5, 2022
Published for Opposition
Jul 5, 2022
Registered

Trademark Image

ZIPDOSE

Basic Information

Serial Number
90859346
Filing Date
July 30, 2021
Published for Opposition
July 5, 2022
Abandonment Date
October 6, 2025
Drawing Code
3

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Oct 6, 2025
Classes
005

Rights Holder

Aprecia Pharmaceuticals, LLC

16
Address
7200 Industrial Row Drive, Suite 200
Mason, OH 45040

Ownership History

Aprecia Pharmaceuticals, LLC

Original Applicant
16
Blue Ash, OH

Aprecia Pharmaceuticals, LLC

Owner at Publication
16
Mason, OH

Legal Representation

Attorney
Brian O'Donnell

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

46 events
Date Code Type Description Documents
Oct 6, 2025 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Oct 6, 2025 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jun 17, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 16, 2025 EX5G S SOU EXTENSION 5 GRANTED Loading...
Jun 16, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Mar 12, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Mar 12, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Mar 12, 2025 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Mar 12, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Mar 12, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Mar 12, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Feb 26, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 25, 2025 EXT5 S SOU EXTENSION 5 FILED Loading...
Aug 19, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 19, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 19, 2024 EXT4 S SOU EXTENSION 4 FILED Loading...
Aug 19, 2024 EX4G S SOU EXTENSION 4 GRANTED Loading...
Feb 29, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 28, 2024 EX3G S SOU EXTENSION 3 GRANTED Loading...
Feb 28, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 28, 2024 EXT3 S SOU EXTENSION 3 FILED Loading...
Aug 30, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 28, 2023 EX2G S SOU EXTENSION 2 GRANTED Loading...
Aug 28, 2023 EXT2 S SOU EXTENSION 2 FILED Loading...
Aug 28, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 1, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 27, 2023 EX1G S SOU EXTENSION 1 GRANTED Loading...
Feb 27, 2023 EXT1 S SOU EXTENSION 1 FILED Loading...
Feb 27, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 30, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 5, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 5, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 15, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 27, 2022 ALIE A ASSIGNED TO LIE Loading...
May 26, 2022 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
May 26, 2022 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
May 26, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 26, 2022 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
May 26, 2022 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
May 23, 2022 ZZZX Z PREVIOUS ALLOWANCE COUNT WITHDRAWN Loading...
May 17, 2022 PBCR Z WITHDRAWN FROM PUB - OG REVIEW QUERY Loading...
May 4, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 27, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 29, 2021 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Sep 28, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 3, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, a drug delivery system consisting of compounds in a unitary solid dosage form for the rapid dispersion of a wide variety of therapeutic agents

Additional Information

Design Mark
The mark consists of the stylized word "ZIPDOSE" inside a rectangle with curved sides on the right and a scalloped edge on the left with nine adjacent rows of five squared dots each in graduated size from the row of largest squared dots immediately adjacent to the scalloped edge of the rectangle to the smallest.

Classification

International Classes
005